2022 Annual Meeting | C142 - Health Equity for Neurologists

Date Wednesday 04/06/22

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Bruce I. Ovbiagele, MD, MSc, FAAN

Topic(s) Health Care Disparities

Learning Objectives By the end of this course comprising three lectures, using exemplary cases or scenarios, participants should be able to: Describe the concepts of health equity, health disparities, vulnerable and underserved populations, social justice, implicit bias, structural racism, and cultural sensitivity; List prevailing major disparities in neurology and promising avenues to bridge them; Appreciate the roles that training and research can play in overcoming neurological disparities; Appreciate that reduction of neurological disparities will require greater emphasis on non-medical (social) determinants of health; Recognize importance of the health system as well as the community and social context as modifiable targets to address brain health equity challenges; Appreciate the need for workforce diversity to address health inequities and neurological disparities; Understand the potential contributions of advocacy and leadership to bridging neurological disparities

CME Available 2.00 CME credits

Core Competencies Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Program Tracks Diversity, Equity, and Inclusion

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
03:30 PM - 04:00 PM PDT	Speaker	Brain Health Equity – Definitions, Determinants, and Disparities Lilyana M. Amezcua, MD, FAAN
03:30 PM - 03:30 PM PDT	Speaker	Walk-in Slides Bruce I. Ovbiagele, MD, MSc, FAAN
04:00 PM - 04:10 PM PDT	Q&A	Questions and Answers Lilyana M. Amezcua, MD, FAAN
04:10 PM - 04:40 PM PDT	Speaker	Brain Health Equity – Awareness, Academics, and Associations Bruce I. Ovbiagele, MD, MSc, FAAN
04:40 PM - 04:50 PM PDT	Q&A	Questions and Answers Bruce I. Ovbiagele, MD, MSc, FAAN
04:50 PM - 05:20 PM PDT	Speaker	Brain Health Equity – Systems, Social Situations, and Society
05:20 PM - 05:30 PM PDT	Q&A	Questions and Answers

Faculty Disclosures
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Lilyana M. Amezcua, MD, FAAN	Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for serono. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Amezcua has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Amezcua has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for genentech. The institution of Dr. Amezcua has received research support from National MS Society. The institution of Dr. Amezcua has received research support from Genentech. The institution of Dr. Amezcua has received research support from Medday. The institution of Dr. Amezcua has received research support from Bristol Myers Squibb Foundation. The institution of Dr. Amezcua has received research support from NIH NINDS.